FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

386951001: Abciximab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1461129011 Abciximab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1481065010 Abciximab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Abciximab Is a Immunologic agent false Inferred relationship Existential restriction modifier
Abciximab Is a Biological agent false Inferred relationship Existential restriction modifier
Abciximab Is a Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Abciximab Has disposition Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Abciximab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Abciximab Is a Substance with murine-human monoclonal immunoglobulin G antibody mechanism of action false Inferred relationship Existential restriction modifier
Abciximab Is a Substance with platelet aggregation inhibitor mechanism of action (substance) false Inferred relationship Existential restriction modifier
Abciximab Has disposition Platelet aggregation inhibitor false Inferred relationship Existential restriction modifier
Abciximab Is a Substance with glycoprotein-IIb/IIIa receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Abciximab Has disposition Platelet glycoprotein-IIb/IIIa receptor antagonist true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing abciximab Has active ingredient True Abciximab Inferred relationship Existential restriction modifier 1
Abciximab 2mg/mL injection solution 5mL vial Has active ingredient False Abciximab Inferred relationship Existential restriction modifier
Abciximab 10mg/5 mL solution Has active ingredient False Abciximab Inferred relationship Existential restriction modifier
Product containing precisely abciximab 10 milligram/5 milliliter conventional release solution for injection vial Has basis of strength substance False Abciximab Inferred relationship Existential restriction modifier 1
Product containing precisely abciximab 10 milligram/5 milliliter conventional release solution for injection vial Has precise active ingredient False Abciximab Inferred relationship Existential restriction modifier 1
Product containing abciximab in parenteral dose form (medicinal product form) Has active ingredient True Abciximab Inferred relationship Existential restriction modifier 1
Abciximab Has active ingredient True Abciximab Inferred relationship Existential restriction modifier 1
Product containing only abciximab in parenteral dose form (medicinal product form) Has active ingredient True Abciximab Inferred relationship Existential restriction modifier 1
Product containing precisely abciximab 2 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Abciximab Inferred relationship Existential restriction modifier 1
Product containing precisely abciximab 2 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Abciximab Inferred relationship Existential restriction modifier 1
Abciximab 10mg/5mL injection - product Has active ingredient False Abciximab Inferred relationship Existential restriction modifier
ReoPro 10mg/5mL injection Has active ingredient False Abciximab Inferred relationship Existential restriction modifier
ReoPro 10mg/5ml solution for injection vials (Eli Lilly & Co Ltd) Has active ingredient True Abciximab Inferred relationship Existential restriction modifier
Abciximab 10mg/5ml solution for injection vials 1 vial Has active ingredient False Abciximab Inferred relationship Existential restriction modifier
ReoPro 10mg/5ml solution for injection vials (Eli Lilly & Co Ltd) 1 vial Has active ingredient False Abciximab Inferred relationship Existential restriction modifier
ReoPro 10mg/5ml solution for injection vials (Eli Lilly & Co Ltd) 1 vial Has specific active ingredient True Abciximab Inferred relationship Existential restriction modifier
Abciximab 2mg/mL injection solution 5mL vial Has specific active ingredient False Abciximab Inferred relationship Existential restriction modifier
ReoPro 10mg/5ml solution for injection vials (Eli Lilly & Co Ltd) Has specific active ingredient True Abciximab Inferred relationship Existential restriction modifier
Abciximab 10mg/5ml solution for injection vials 1 vial Has specific active ingredient True Abciximab Inferred relationship Existential restriction modifier
Abciximab 10mg/5ml solution for injection vials Has active ingredient False Abciximab Inferred relationship Existential restriction modifier
Abciximab 10mg/5ml solution for injection vials Has active ingredient False Abciximab Inferred relationship Existential restriction modifier
Abciximab 10mg/5ml solution for injection vials Has specific active ingredient True Abciximab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start